Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) 

75 Sidney Street, 4th Floor

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-299-5000 Fax: 617-995-4995


 Key Statistics

Ownership: Public

Web Site: AVEO Oncology
Symbol: AVEO


Merck & Co.  Cancer

 Company News
AVEO Oncology (AVEO) Names Keith S. Ehrlich As Chief Financial Officer 4/22/2015 11:01:58 AM
AVEO Oncology (AVEO) Announces Presentation Of AV-380 Preclinical Data In Cancer Associated Cachexia At 2015 Annual Meeting Of The AACR 4/20/2015 11:20:58 AM
AVEO Oncology (AVEO) Announces Presentation Of Phase 2 Study Analysis Showing Longer PFS With Tivozanib Compared To Bevacizumab In Low Serum NRP-1 Patients With Advanced CRC 3/6/2015 10:42:02 AM
AVEO Oncology (AVEO) Reports Full Year 2014 Financial Results 3/6/2015 7:49:53 AM
AVEO Oncology (AVEO) To Host Conference Call To Discuss Presentation Of Final Results And Biomarker Analysis From Phase 2 Study Of Tivozanib In Patients With Advanced Colorectal Cancer 2/27/2015 10:53:27 AM
AVEO Oncology (AVEO) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/12/2015 10:25:03 AM
AVEO Oncology (AVEO) Names Michael N. Needle, M.D., As Chief Medical Officer 1/9/2015 9:42:52 AM
AVEO Oncology (AVEO) Receives Confirmation Of Eligibility For Submission Of A Tivozanib Marketing Authorization Application To European Medicines Agency 1/8/2015 11:35:41 AM
Cambridge's AVEO Oncology (AVEO) Chops Two-Thirds of Workforce 1/7/2015 6:17:14 AM
AVEO Oncology (AVEO)'s Comeback Hits a Snag as Nasdaq Warns It Could be Delisted 12/31/2014 6:10:34 AM